Chemoinformaics analysis of 3-Methoxybenzaldehyde
| Molecular Weight | 136.15 | nRot | 2 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 7 |
| Exact Molecular Weight | 136.052 | nRing | 1 |
| Solubility: LogS | -1.874 | nHRing | 0 |
| Solubility: LogP | 1.673 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 20.2983 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.576 |
| Synth | 1.594 |
| Natural Product Likeliness | -0.252 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.008 |
| HIA | 0.012 |
| CACO-2 | -4.395 |
| MDCK | 0.0000183 |
| BBB | 0.991 |
| PPB | 0.806182 |
| VDSS | 1.046 |
| FU | 0.130562 |
| CYP1A2-inh | 0.951 |
| CYP1A2-sub | 0.821 |
| CYP2c19-inh | 0.428 |
| CYP2c19-sub | 0.644 |
| CYP2c9-inh | 0.059 |
| CYP2c9-sub | 0.823 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.81 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.254 |
| CL | 7.999 |
| T12 | 0.756 |
| hERG | 0.083 |
| Ames | 0.032 |
| ROA | 0.014 |
| SkinSen | 0.483 |
| Carcinogencity | 0.052 |
| EI | 0.995 |
| Respiratory | 0.876 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.890946 |